Cary, N.C. – January 4, 2012 – Industry Standard Research (ISR) today announced the release of a new report titled “Clinical Imaging Market Dynamics and Service Provider Performance” in which 36 pharmaceutical sponsor decision-makers provide their usage, insights, and forecasts regarding the clinical imaging market by rating 98 service provider encounters. “The clinical imaging market is growing and there are many highly qualified service providers that pharmaceutical sponsors can consider to support their clinical trials. The imaging market is similar to the Phase I and ECG markets in that it is a highly outsourced activity and you have fit-for-purpose specialized providers competing alongside large, multi-service CROs offering a similar service” explained Andrew Schafer, President of Industry Standard Research. The report addresses service provider performance and selection criteria which allow pharmaceutical companies an independent look into many of the top service providers in the industry and it gives service providers a competitive assessment of their strengths and weaknesses. “The pharmaceutical decision-makers we spoke to indicated they don’t typically use the same service provider on a study for both imaging services and clinical operations and they prefer to use a specialized imaging provider. However, respondents rated the performance of the multi-service CROs higher than the specialized imaging providers” Schafer explained. Each service provider has its own strengths and weaknesses and there is room for differentiation. “By taking a comprehensive look at the overall industry growth rate, the propensity to outsource, service provider usage and preference, and the performance of 11 leading imaging providers we are able to provide readers novel insights into the imaging market they can use to make better outsourcing decisions, improve trial performance, and better position their companies for success” Schafer explained. About Industry Standard Research Industry Standard Research is the premier, full service market research provider to the pharma and pharma services industries.  With over a decade of experience in the industry, ISR delivers an unmatched level of domain expertise.  For more information about our off-the-shelf intelligence and custom research offerings, please visit the company’s Web site at, e-mail, or follow us on twitter @ISRreports.